Modesto, CA7 Active Studies

Rheumatoid Arthritis Clinical Trials in Modesto, CA

Find 7 actively recruiting rheumatoid arthritis clinical trials in Modesto, CA. Connect with local research sites and explore new treatment options.

7
Active Trials
6
Sponsors
2,200
Enrolling

Recruiting Rheumatoid Arthritis Studies in Modesto

RecruitingModesto, CANCT06556368

A Study to Evaluate the Efficacy and Safety of Tarcocimab Tedromer and Tabirafusp Tedromer Compared to Aflibercept in Participants With Neovascular (Wet) Age-related Macular Degeneration (wAMD) - DAYBREAK

A Study to Evaluate the Efficacy and Safety of Tarcocimab Tedromer and Tabirafusp Tedromer Compared to Aflibercept in Participants with Neovascular (Wet) Age-related Macular Degeneration (wAMD)...

675 participants
Kodiak Sciences Inc
View Study Details
RecruitingModesto, CANCT06510816

A Study Investigating the Efficacy and Safety of Intravitreal (IVT) Injections of ANX007 in Participants With Geographic Atrophy (GA)

The primary purpose of the study is to determine if IVT injections of ANX007 every month reduce vision loss in participants with GA secondary to age-related macular degeneration (AMD)....

630 participants
Annexon, Inc.
View Study Details
RecruitingModesto, CANCT04628767

Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer

This phase II/III trial compares the effect of adding durvalumab to chemotherapy versus chemotherapy alone before surgery in treating patients with upper urinary tract cancer. Immunotherapy with monoc...

249 participants
National Cancer Institute (NCI)
View Study Details
RecruitingModesto, CANCT05438212

Comparing the Addition of Radiation Either Before or After Surgery for Patients With Brain Metastases

This phase III trial compares the usual treatment of surgery after stereotactic radiosurgery (SRS) to receiving SRS before surgery in treating patients with cancer that has spread to the brain (brain ...

236 participants
NRG Oncology
View Study Details
RecruitingModesto, CANCT06722157

A Study to Test Whether BI 771716 Helps People With an Advanced Form of Age-related Macular Degeneration (AMD) Called Geographic Atrophy

This study is open to people 50 years or older with an eye condition called geographic atrophy. The purpose of this study is to compare a medicine called BI 771716 with a medicine called pegcetacoplan...

180 participants
Boehringer Ingelheim
View Study Details
RecruitingModesto, CANCT06769048

A Study to Test Different Doses of BI 1584862 in People With a Distinct Form of Age-related Macular Degeneration (AMD) Called Geographic Atrophy

This study is open to adults aged 50 years and older with geographic atrophy that was diagnosed by imaging of the retina. The purpose of this study is to find out whether a medicine called BI 1584862 ...

138 participants
Boehringer Ingelheim
View Study Details
RecruitingModesto, CANCT06664502

A 2-part Study Consisting of a Multiple Ascending Dose Safety Study in Participants With Macular Edema Following Branch Retinal Vein Occlusion and a Dose-finding Safety and Preliminary Efficacy Study in Participants With Either Diabetic Macular Edema or Neovascular Age-related Macular Degeneration

EYE-TIE-201 is a 2-part study to investigate the safety and effectiveness of a new drug being developed called EYE201. All participants in the study will receive a total of 3 injections of EYE201 int...

92 participants
EyeBiotech Ltd.
View Study Details

About Rheumatoid Arthritis Clinical Trials in Modesto

Rheumatoid arthritis (RA) is a chronic autoimmune disease affecting approximately 1.3 million Americans, where the immune system mistakenly attacks joint linings, causing painful swelling, bone erosion, and joint deformity. Early diagnosis and treatment are critical to prevent irreversible damage. Current standard treatments include methotrexate and other DMARDs, TNF inhibitors (etanercept, infliximab), IL-6 inhibitors (tocilizumab), T-cell costimulation modulators (abatacept), and JAK inhibitors (tofacitinib, baricitinib). Clinical trials are now exploring next-generation targeted therapies, dual-pathway inhibitors, and treatment strategies aimed at achieving sustained remission rather than just symptom control. Patients with inadequate response to conventional DMARDs or biologics are commonly eligible for enrollment.

There are currently 7 rheumatoid arthritis clinical trials recruiting participants in Modesto, CA. These studies are seeking a combined 2,200 participants. Research is being sponsored by Kodiak Sciences Inc, Annexon, Inc., National Cancer Institute (NCI) and 3 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Rheumatoid Arthritis Clinical Trials in Modesto — FAQ

Are there rheumatoid arthritis clinical trials in Modesto?

Yes, there are 7 rheumatoid arthritis clinical trials currently recruiting in Modesto, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Modesto?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Modesto research site will contact you about next steps.

Are clinical trials in Modesto free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Modesto studies also compensate for your time and travel.

What rheumatoid arthritis treatments are being tested?

The 7 active trials in Modesto are testing new therapies including novel drugs, biologics, and treatment approaches for rheumatoid arthritis.

Data updated March 2, 2026 from ClinicalTrials.gov